Doctors are of the creed that, the materialization of novel mutations of Corona virus in Southern African Region, have resulted to an upsurge in the number of cases of Covid-19 and deaths that were documented inside many countries in Sub-Saharan Africa.

There has been another wave of the global pandemic, in at least forty-40 African nations, inclusive of all the countries in the southern African region, this position, was stated by the Africa Centre for Disease Control (CDC). The occurring second wave of the Corona virus disease pandemic, is believed to be associated with the arrival of novel variants of the Corona virus, these new variants, are more virulent . According to the World Health Organization (W.H.O), in recent months, a new variant of the virus emerged in South Africa and this mutant has led to an increase in the accounted numbers of cases, in the southern African region.

In other areas of the African continent, this novel strain of the Corona virus disease, has been officially accounted for in Tanzania, Mozambique, Zambia, Botswana, Kenya, Comoros and Ghana; there exists the possibility of the new variant of Corona virus reaching other countries on the African continent, however, most countries in Africa, are bereft of the much needed financial requirements and well trained health staff, that are required to conduct very technical sequencing of the D.N.A, needed to discover and pinpoint the novel strains of the Corona virus disease.

According to the W.H.O, in recently conducted medical laboratory diagnostic test, results have indicated that, the Corona virus variant of the virus in South Africa is very transmissible amongst the citizens. Recently, in just concluded study carried out by the University of Witwatersrand, the Oxford-Astra Zeneca Corona virus vaccine, the first Corona virus vaccine that landed in South Africa, offers little panacea against clement and mellow cases of Corona Virus, that manifested from the new mutants of the Corona virus disease. The recent study carried out by the University of Witwatersrand, did not study the vaccine's efficacy, in stopping dangerous Corona virus disease contaminations. The Oxford-AstraZeneca Covid-19 vaccine, is a vaccine that was manufactured by a joint venture partnership between the University of Oxford and AstraZeneca Plc; AstraZeneca Plc, is a British-Swedish multinational pharmaceutical and biotechnology corporation, that has its headquarters located at the University of Cambridge Biomedical Campus, in Cambridge England.

Currently, there is an immediate and pressing demand, for individuals, banks, insurance companies, financial institutions, hedge funds, corporate organizations, mining companies, venture capitalists, international donors and philanthropists, to offer assistance to the efforts of health professionals and health experts, across the continent of Africa, that are working tirelessly to extirpate the Corona Virus and make sure that the Corona Virus is totally rooted out for the wellbeing of people of Africa and the African continent in its entirety.